Phase i and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies

Giles, F J; Vey, N; Rizzieri, D; Ravandi, F; Prebet, T; Borthakur, G; Jacobsen, T F; Hagen, S; Nilsson, B; O'Brien, S

View/Open

Full Text

Date

2012-01-06

Author

Giles, F J

Vey, N

Rizzieri, D

Ravandi, F

Prebet, T

Borthakur, G

Jacobsen, T F

Hagen, S

Nilsson, B

O'Brien, S

Metadata

Show full item record

Usage

This item's downloads: 0 (view details)

Recommended Citation

Giles, F J; Vey, N; Rizzieri, D; Ravandi, F; Prebet, T; Borthakur, G; Jacobsen, T F; Hagen, S; Nilsson, B; O'Brien, S (2012). Phase i and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies. Leukemia 26 (7), 1686-1689

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland